AN
argenx NV ADR
🇺🇸XNAS.ARGXUnited StatesHealthcare
$975.14USDdown -4.50 (-0.46%)OpenDelayed3:28 PM
Price$975.14-4.50 (-0.46%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US04016X1019
- CUSIP
- 04016X101
Company
- Employees
- 1,863
- Headquarters
- Amsterdam, United States
- Website
- https://argenx.com
- CEO
- Ms. Karen Massey
Market
- Shares outstanding
- 62.2M
- Market cap
- $60.64B
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- $60.86B
- EPS LTM
- $41.74calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 23.36calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $8.45B+130.89%up year on year
- Net income
- $2.6B+89.22%up year on year
- Gross margin
- 89.94%+19.96%up year on year
- Free cash flow
- $1.16B+144.05%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.